Expression of complement components differs between kidney allografts from living and deceased donors.

Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes. Kidney Int (2011) 2.50

Integrative urinary peptidomics in renal transplantation identifies biomarkers for acute rejection. J Am Soc Nephrol (2010) 2.00

A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation. J Exp Med (2013) 1.47

Clinical role of the renal transplant biopsy. Nat Rev Nephrol (2012) 1.46

The role of complement in the early immune response to transplantation. Nat Rev Immunol (2012) 1.26

Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis. J Transl Med (2011) 1.15

Complement in organ transplantation. Curr Opin Organ Transplant (2010) 1.08

Molecular diagnostics in transplantation. Nat Rev Nephrol (2010) 1.01

Complement regulation of T cell immunity. Immunol Res (2012) 0.95

Molecules Great and Small: The Complement System. Clin J Am Soc Nephrol (2015) 0.91

The predictive value of kidney allograft baseline biopsies for long-term graft survival. J Am Soc Nephrol (2013) 0.89

Complement as a multifaceted modulator of kidney transplant injury. J Clin Invest (2014) 0.89

The role of complement in the pathogenesis of renal ischemia-reperfusion injury and fibrosis. Fibrogenesis Tissue Repair (2014) 0.86

Evolving paradigms that determine the fate of an allograft. Am J Transplant (2010) 0.86

The role of the complement system in acute kidney injury. Semin Nephrol (2013) 0.83

Assessment of kidney organ quality and prediction of outcome at time of transplantation. Semin Immunopathol (2011) 0.82

Meta-analysis of molecular response of kidney to ischemia reperfusion injury for the identification of new candidate genes. BMC Nephrol (2013) 0.82

Complement regulation of T-cell alloimmunity. Semin Nephrol (2013) 0.81

The innate immune system and transplantation. Cold Spring Harb Perspect Med (2013) 0.79

Complement regulation of T-cell alloimmunity. Curr Opin Organ Transplant (2011) 0.78

Complement activation in progressive renal disease. World J Nephrol (2015) 0.77

Atypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literature. Front Med (Lausanne) (2014) 0.77

Post-Transplant Diabetes Mellitus: Causes, Treatment, and Impact on Outcomes. Endocr Rev (2015) 0.76

Noninvasive Imaging of Activated Complement in Ischemia-Reperfusion Injury Post-Cardiac Transplant. Am J Transplant (2015) 0.76

Amelioration of renal damage by administration of anti-thymocyte globulin to potential donors in a brain death rat model. Clin Exp Immunol (2012) 0.76

Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts. Curr Opin Organ Transplant (2016) 0.75

Targeted complement inhibition and microvasculature in transplants: a therapeutic perspective. Clin Exp Immunol (2015) 0.75

Complement in Kidney Transplantation. Front Med (Lausanne) (2017) 0.75

Assessment of Circulating Protein Signatures for Kidney Transplantation in Pediatric Recipients. Front Med (Lausanne) (2017) 0.75

Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A (1998) 192.97

Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A (2001) 132.88

Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci U S A (2001) 68.44

Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A (2002) 30.32

PANTHER: a library of protein families and subfamilies indexed by function. Genome Res (2003) 21.64

Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med (2000) 6.65

Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39

Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science (2000) 5.10

The complement system in regulation of adaptive immunity. Nat Immunol (2004) 4.58

A transcriptional profile of aging in the human kidney. PLoS Biol (2004) 3.69

Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med (2002) 3.39

Antibody-mediated renal allograft rejection: diagnosis and pathogenesis. J Am Soc Nephrol (2007) 2.64

Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest (2000) 2.45

CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann Med (2004) 2.33

Inflammatory cells in ischemic acute renal failure. Kidney Int (2004) 2.20

Osteopontin--a molecule for all seasons. QJM (2002) 2.09

Influence of donor C3 allotype on late renal-transplantation outcome. N Engl J Med (2006) 1.97

Rap1 GTPase inhibits leukocyte transmigration by promoting endothelial barrier function. J Biol Chem (2005) 1.84

Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion. J Clin Invest (2006) 1.57

Multifunctional roles of lactoferrin: a critical overview. Cell Mol Life Sci (2005) 1.48

Cold ischemia and the reduced long-term survival of cadaveric renal allografts. Kidney Int (2004) 1.46

A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats. Kidney Int (2003) 1.41

Local extravascular pool of C3 is a determinant of postischemic acute renal failure. FASEB J (2006) 1.38

Treatment with an inhibitory monoclonal antibody to mouse factor B protects mice from induction of apoptosis and renal ischemia/reperfusion injury. J Am Soc Nephrol (2006) 1.32

Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation. Transplantation (2003) 1.27

Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation. Transplantation (2003) 1.23

The transcriptome of the implant biopsy identifies donor kidneys at increased risk of delayed graft function. Am J Transplant (2007) 1.13

Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice. J Immunol (2006) 1.12

Synthesis of complement protein C3 in the kidney is an important mediator of local tissue injury. FASEB J (2007) 1.11

Therapeutic strategy with a membrane-localizing complement regulator to increase the number of usable donor organs after prolonged cold storage. J Am Soc Nephrol (2006) 1.08

Inhibition of terminal complement components in presensitized transplant recipients prevents antibody-mediated rejection leading to long-term graft survival and accommodation. J Immunol (2007) 1.07

C6 mediates chronic progression of tubulointerstitial damage in rats with remnant kidneys. J Am Soc Nephrol (2002) 1.05

Differential expression of complement C3 and C4 in the human kidney. J Clin Invest (1993) 1.02

Complement inhibitors targeted to the proximal tubule prevent injury in experimental nephrotic syndrome and demonstrate a key role for C5b-9. J Immunol (2005) 1.01

Genome-wide gene-expression patterns of donor kidney biopsies distinguish primary allograft function. Lab Invest (2004) 1.01

The relative importance of local and systemic complement production in ischaemia, transplantation and other pathologies. Mol Immunol (2007) 1.00

Excessive matrix accumulation in the kidneys of MRL/lpr lupus mice is dependent on complement activation. J Am Soc Nephrol (2003) 0.99

Enhanced biological activity of polymeric osteopontin. FEBS Lett (2007) 0.98

The evolution of nonimmune histological injury and its clinical relevance in adult-sized kidney grafts in pediatric recipients. Am J Transplant (2007) 0.97

Nontransgenic hyperexpression of a complement regulator in donor kidney modulates transplant ischemia/reperfusion damage, acute rejection, and chronic nephropathy. Am J Pathol (2003) 0.97

Complement activation regulates the capacity of proximal tubular epithelial cell to stimulate alloreactive T cell response. J Am Soc Nephrol (2004) 0.94

Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat. Am J Pathol (1996) 0.93

Alterations in gene expression in cadaveric vs. live donor kidneys suggest impaired tubular counterbalance of oxidative stress at implantation. Am J Transplant (2004) 0.92

Kidney grafts from brain dead donors: Inferior quality or opportunity for improvement? Kidney Int (2007) 0.91

Capillary deposition of complement C4d and C3d in pediatric renal allograft biopsies. Transplantation (2005) 0.90

Trends in organ donation and transplantation in the United States, 1996-2005. Am J Transplant (2007) 0.89

CKbeta8, a novel CC chemokine that predominantly acts on monocytes. FEBS Lett (1997) 0.89

Local complement C3 expression is upregulated in humoral and cellular rejection of renal allografts. Am J Transplant (2005) 0.89

Activation of the terminal complement cascade in renal infarction. Kidney Int (1995) 0.81

CD40 ligand increases complement C3 secretion by proximal tubular epithelial cells. J Am Soc Nephrol (2005) 0.79

Role of complement in renal tubular damage. Histopathology (1995) 0.79

C4d deposition in the peritubular capillaries of native renal biopsies. Histopathology (2005) 0.77

The diploid genome sequence of an Asian individual. Nature (2008) 46.29

A draft sequence of the rice genome (Oryza sativa L. ssp. indica). Science (2002) 42.78

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med (2003) 26.05

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A (2003) 17.10

The sequence and de novo assembly of the giant panda genome. Nature (2009) 15.76

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev (2007) 13.05

Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell (2012) 12.32

Diverse somatic mutation patterns and pathway alterations in human cancers. Nature (2010) 10.83

Clinical assessment incorporating a personal genome. Lancet (2010) 10.18

TEAD mediates YAP-dependent gene induction and growth control. Genes Dev (2008) 9.88

Regulation of TORC1 by Rag GTPases in nutrient response. Nat Cell Biol (2008) 8.92

The genome of the cucumber, Cucumis sativus L. Nat Genet (2009) 8.19

An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people. Science (2012) 7.94

ZDOCK: an initial-stage protein-docking algorithm. Proteins (2003) 7.52

Performance comparison of exome DNA sequencing technologies. Nat Biotechnol (2011) 7.11

Gene discovery and annotation using LCM-454 transcriptome sequencing. Genome Res (2006) 7.10

The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol (2010) 7.08

Analysis of matched mRNA measurements from two different microarray technologies. Bioinformatics (2002) 7.07

A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Hum Mol Genet (2003) 6.82

Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput Biol (2012) 6.38

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med (2011) 6.35

Ontology-driven indexing of public datasets for translational bioinformatics. BMC Bioinformatics (2009) 6.31

Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination. Vaccine (2009) 6.30

PlasmoDB: the Plasmodium genome resource. A database integrating experimental and computational data. Nucleic Acids Res (2003) 6.19

The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev (2010) 6.05

SNP discovery via 454 transcriptome sequencing. Plant J (2007) 5.92

Performance comparison of whole-genome sequencing platforms. Nat Biotechnol (2011) 5.79

Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci Transl Med (2011) 5.77

MicroRNA-mediated conversion of human fibroblasts to neurons. Nature (2011) 5.59

A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev (2010) 5.38

The oyster genome reveals stress adaptation and complexity of shell formation. Nature (2012) 5.30

Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci Transl Med (2011) 5.30

A porous supramolecular architecture from a copper(II) coordination polymer with a 3D four-connected 8(6) net. Inorg Chem (2003) 5.16

Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch Neurol (2007) 5.09

Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome. J Exp Med (2007) 4.95

Stability of the regulatory T cell lineage in vivo. Science (2010) 4.89

Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med (2007) 4.80

Cell type-specific gene expression differences in complex tissues. Nat Methods (2010) 4.75

An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitus. PLoS One (2010) 4.42

The Plasmodium genome database. Nature (2002) 4.36

Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N Engl J Med (2003) 4.35

Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol (2012) 4.26

Intrarenal resistive index after renal transplantation. N Engl J Med (2013) 4.19

Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood (2003) 3.98

Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment. Am J Clin Nutr (2004) 3.96

Germline gain-of-function mutations in SOS1 cause Noonan syndrome. Nat Genet (2006) 3.81

Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Genome Biol (2006) 3.75

FoxO3 regulates neural stem cell homeostasis. Cell Stem Cell (2009) 3.54

Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev (2012) 3.48

Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Blood (2007) 3.27

Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes. Proc Natl Acad Sci U S A (2012) 3.27

ToxoDB: accessing the Toxoplasma gondii genome. Nucleic Acids Res (2003) 3.24

Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets. PLoS Comput Biol (2010) 3.23

Phased whole-genome genetic risk in a family quartet using a major allele reference sequence. PLoS Genet (2011) 3.20

Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev (2011) 3.15

A mouse knockout library for secreted and transmembrane proteins. Nat Biotechnol (2010) 3.09

Gene density, transcription, and insulators contribute to the partition of the Drosophila genome into physical domains. Mol Cell (2012) 3.08

Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol (2003) 3.02

Mouse neuroinvasive phenotype of West Nile virus strains varies depending upon virus genotype. Virology (2002) 2.96

Challenges in the clinical application of whole-genome sequencing. Lancet (2010) 2.92

Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol (2012) 2.91

Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity (2004) 2.89

Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome. Immunity (2009) 2.84

Increased intratumoral IL-17-producing cells correlate with poor survival in hepatocellular carcinoma patients. J Hepatol (2009) 2.84

Systematic survey reveals general applicability of "guilt-by-association" within gene coexpression networks. BMC Bioinformatics (2005) 2.83

Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy. Cancer Res (2011) 2.71

A highly sensitive CMOS digital Hall sensor for low magnetic field applications. Sensors (Basel) (2012) 2.69

Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia. Blood (2006) 2.69

Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin. Nat Cell Biol (2005) 2.68

Mutations in myosin light chain kinase cause familial aortic dissections. Am J Hum Genet (2010) 2.67

Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family. Cell Stem Cell (2008) 2.67

Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers. Mol Cancer Res (2009) 2.65

Genomic characterization of non-O1, non-O139 Vibrio cholerae reveals genes for a type III secretion system. Proc Natl Acad Sci U S A (2005) 2.65

Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis (2009) 2.62

A review of EPAP nasal device therapy for obstructive sleep apnea syndrome. Sleep Breath (2014) 2.61

Computerized recruiting for clinical trials in real time. Ann Emerg Med (2003) 2.59

Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection. Nat Med (2004) 2.59

The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds. Mol Cell Biol (2008) 2.57

Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns. Circulation (2010) 2.57

A Kir2.1 gain-of-function mutation underlies familial atrial fibrillation. Biochem Biophys Res Commun (2005) 2.55

The mitochondrial inner membrane protein mitofilin controls cristae morphology. Mol Biol Cell (2005) 2.53

Exploiting drug-disease relationships for computational drug repositioning. Brief Bioinform (2011) 2.52

Quantifying the relationship between co-expression, co-regulation and gene function. BMC Bioinformatics (2004) 2.51

Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes. Kidney Int (2011) 2.50

AILUN: reannotating gene expression data automatically. Nat Methods (2007) 2.47

High-resolution genomic and expression analyses of copy number alterations in breast tumors. Genes Chromosomes Cancer (2008) 2.46

A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. Cancer Discov (2013) 2.46

1,1'-[(Hexane-1,6-diyldi-oxy)bis-(nitrilo-methyl-idyne)]dinaphthalene. Acta Crystallogr Sect E Struct Rep Online (2008) 2.45

MicroRNA profiling of human-induced pluripotent stem cells. Stem Cells Dev (2009) 2.44